These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 10446993)
1. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Chang BD; Broude EV; Dokmanovic M; Zhu H; Ruth A; Xuan Y; Kandel ES; Lausch E; Christov K; Roninson IB Cancer Res; 1999 Aug; 59(15):3761-7. PubMed ID: 10446993 [TBL] [Abstract][Full Text] [Related]
2. Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Chang BD; Xuan Y; Broude EV; Zhu H; Schott B; Fang J; Roninson IB Oncogene; 1999 Aug; 18(34):4808-18. PubMed ID: 10490814 [TBL] [Abstract][Full Text] [Related]
3. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Roninson IB; Broude EV; Chang BD Drug Resist Updat; 2001 Oct; 4(5):303-13. PubMed ID: 11991684 [TBL] [Abstract][Full Text] [Related]
4. Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Gewirtz DA; Holt SE; Elmore LW Biochem Pharmacol; 2008 Oct; 76(8):947-57. PubMed ID: 18657518 [TBL] [Abstract][Full Text] [Related]
5. Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence. Byun HO; Han NK; Lee HJ; Kim KB; Ko YG; Yoon G; Lee YS; Hong SI; Lee JS Cancer Res; 2009 Jun; 69(11):4638-47. PubMed ID: 19487283 [TBL] [Abstract][Full Text] [Related]
6. Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response. Elmore LW; Di X; Dumur C; Holt SE; Gewirtz DA Clin Cancer Res; 2005 Apr; 11(7):2637-43. PubMed ID: 15814644 [TBL] [Abstract][Full Text] [Related]
7. Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells. Chen Y; Dokmanovic M; Stein WD; Ardecky RJ; Roninson IB Cancer Res; 2006 Sep; 66(17):8749-61. PubMed ID: 16951191 [TBL] [Abstract][Full Text] [Related]
8. E1A oncogene-induced sensitization of human tumor cells to innate immune defenses and chemotherapy-induced apoptosis in vitro and in vivo. Cook JL; Miura TA; Iklé DN; Lewis AM; Routes JM Cancer Res; 2003 Jun; 63(12):3435-43. PubMed ID: 12810682 [TBL] [Abstract][Full Text] [Related]
9. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
10. Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. Hattangadi DK; DeMasters GA; Walker TD; Jones KR; Di X; Newsham IF; Gewirtz DA Biochem Pharmacol; 2004 Nov; 68(9):1699-708. PubMed ID: 15450935 [TBL] [Abstract][Full Text] [Related]
11. Ionizing radiation but not anticancer drugs causes cell cycle arrest and failure to activate the mitochondrial death pathway in MCF-7 breast carcinoma cells. Jänicke RU; Engels IH; Dunkern T; Kaina B; Schulze-Osthoff K; Porter AG Oncogene; 2001 Aug; 20(36):5043-53. PubMed ID: 11526489 [TBL] [Abstract][Full Text] [Related]
12. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Eom YW; Kim MA; Park SS; Goo MJ; Kwon HJ; Sohn S; Kim WH; Yoon G; Choi KS Oncogene; 2005 Jul; 24(30):4765-77. PubMed ID: 15870702 [TBL] [Abstract][Full Text] [Related]
13. Tumor initiating cancer stem cells from human breast cancer cell lines. Han JS; Crowe DL Int J Oncol; 2009 May; 34(5):1449-53. PubMed ID: 19360358 [TBL] [Abstract][Full Text] [Related]
14. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789 [TBL] [Abstract][Full Text] [Related]
15. Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Roberson RS; Kussick SJ; Vallieres E; Chen SY; Wu DY Cancer Res; 2005 Apr; 65(7):2795-803. PubMed ID: 15805280 [TBL] [Abstract][Full Text] [Related]
16. Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents. De Larco JE; Wuertz BR; Manivel JC; Furcht LT Cancer Res; 2001 Apr; 61(7):2857-61. PubMed ID: 11306458 [TBL] [Abstract][Full Text] [Related]
17. Induction of senescence-like phenotype and loss of paclitaxel sensitivity after wild-type p53 gene transfection of p53-null human non-small cell lung cancer H358 cells. Ling YH; Zou Y; Perez-Soler R Anticancer Res; 2000; 20(2A):693-702. PubMed ID: 10810342 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs. Gewirtz DA; Di X; Walker TD; Sawyer ST Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039 [TBL] [Abstract][Full Text] [Related]
19. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688 [TBL] [Abstract][Full Text] [Related]
20. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]